<DOC>
	<DOCNO>NCT00020631</DOCNO>
	<brief_summary>RATIONALE : Pirfenidone may prevent lessen fibrosis cause radiation therapy . PURPOSE : Pilot trial study effectiveness pirfenidone prevent lessen fibrosis patient undergone radiation therapy cancer .</brief_summary>
	<brief_title>Pirfenidone Treating Patients With Fibrosis Caused Radiation Therapy Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine safety therapeutic efficacy pirfenidone cancer patient radiation-induced fibrosis . OUTLINE : Patients receive oral pirfenidone 3 time daily . Treatment continue 2 year absence disease progression unacceptable toxicity . Principal functional ability assess baseline , every 3 month , termination therapy . PROJECTED ACCRUAL : A total 10-25 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Radiation Pneumonitis</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Regional postradiation fibrosis specific body area ( e.g. , neck , back , extremity ) At least moderate impairment least 1 follow principal functional ability : Range motion Strength Edema Swallowing Prior radiation cancer receive 6 month ago No evidence recurrent metastatic cancer No history collagen vascular disease No positive antinuclear antibody PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Hepatitis B C negative Renal : Not specify Other : HIV negative No evidence second primary cancer No lifethreatening situation require rehabilitation intervention Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent anticancer immunotherapy Chemotherapy : No concurrent anticancer chemotherapy Endocrine therapy : No concurrent anticancer hormonal therapy Radiotherapy : See Disease Characteristics No concurrent anticancer radiotherapy Surgery : Not specify Other : No concurrent anticancer investigational agent Stable dos medicine ( e.g. , nonsteroidal antiinflammatory drug ) currently take allowed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>radiation fibrosis</keyword>
</DOC>